Breastfeeding News and Research RSS Feed - Breastfeeding News and Research

Many women choose to breastfeed their babies due to the significant health benefits provided over infant formula for both baby and mother.

Breast milk contains all the nutrients a baby requires for the first six months of life. Following this period, solid foods can gradually be introduced. The World Health Organization recommends feeding babies exclusively on breast milk for the first six months of life and then continuing breastfeeding once the infant has started to eat solid food, until up to two years of age.

Antibodies present in the breast milk boost the baby’s immune system and decrease the likelihood of diarrhoea, vomiting, or chest and ear infections developing. Breast feeding is also thought to decrease the risk of obesity later in life and therefore reduces the likelihood of conditions such as type 2 diabetes developing. Breast milk is also easier to digest than commercial formula.

For the mother, breastfeeding lowers the risk for breast and ovarian cancer as well as expending up to 500 calories a day, saving money, and helping to build a strong bond with the baby.

Any amount of breastfeeding has positive effects and the longer a child is breastfed for, the longer the health benefits will last for both baby and mother.
University of Salford’s Midwifery Directorate retains UNICEF Baby Friendly accreditation

University of Salford’s Midwifery Directorate retains UNICEF Baby Friendly accreditation

The University of Salford’s Midwifery Directorate has retained its UNICEF Baby Friendly accreditation with flying colours after receiving the UK’s highest ever mark. [More]
New moms don't receive advice on infant care from physicians, study finds

New moms don't receive advice on infant care from physicians, study finds

Many new mothers do not receive advice from physicians on aspects of infant care such as sleep position, breastfeeding, immunization and pacifier use, according to a study funded by the National Institutes of Health. [More]
Study reveals impact of patient navigator program on no-show rates for cervical cancer screening

Study reveals impact of patient navigator program on no-show rates for cervical cancer screening

Researchers at Harvard Medical School and Brigham and Women's Hospital reported a 20% decline in the rate of missed appointments for cervical cancer evaluation following a Pap smear when a patient navigator program was initiated at the referral center. [More]
FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors. [More]
PolyU researchers create comprehensive breast milk nutrient database in Hong Kong

PolyU researchers create comprehensive breast milk nutrient database in Hong Kong

Breastfeeding has become more common all across the world in recent years, however, breastfeeding rate has remained low in Hong Kong. One of the main reasons is that Hong Kong mothers worry about the nutrient adequacy of their breast milk to meet the growing needs of the infant. [More]
Mothers of infants with Down's syndrome need tailored breastfeeding guidance

Mothers of infants with Down's syndrome need tailored breastfeeding guidance

Despite compelling evidence about the benefits of breastfeeding little is known about the breastfeeding experiences of mothers of infants with Down's syndrome. In the UK, clinical commissioning groups and practitioners have a vital role in empowering and enabling these women to access help and support as soon as the child is born. [More]
News study shows pregnancy complications tied to future cardiovascular disease risk

News study shows pregnancy complications tied to future cardiovascular disease risk

According to a new study, women can accurately recall key pregnancy-related information at least 4 years later that could have important implications for their future risk of developing cardiovascular disease (CVD). [More]
New collection of papers adds to mounting evidence of gut microbiome’s influential role in health

New collection of papers adds to mounting evidence of gut microbiome’s influential role in health

A newly released collection of papers, the result of the Gut in Focus Symposium Nobel Forum held earlier this year, is adding to the mounting evidence of the influential role the gut microbiome plays in health. [More]
Study: Osteopathic manipulative therapy decreases low back pain by over 70% in postpartum women

Study: Osteopathic manipulative therapy decreases low back pain by over 70% in postpartum women

German researchers found osteopathic manipulative therapy (OMTh) decreased postpartum low back pain by over 70 percent in women who had given birth at least three months before beginning treatment, according to a new study published in July issue of the Journal of the American Osteopathic Association. [More]
Health Canada informs Canadians that eight unauthorized health products were seized from Better Bodies Supplements

Health Canada informs Canadians that eight unauthorized health products were seized from Better Bodies Supplements

Health Canada is informing Canadians that eight unauthorized health products (listed in the table below) were seized from Better Bodies Supplements, 118 Main Street North, in Airdrie, Alta. [More]
Vitamin K-deficient bleeding increasingly common in newborns

Vitamin K-deficient bleeding increasingly common in newborns

Vitamin K, which has been administered to newborns as an injection since it was first recommended by the American Academy of Pediatrics in 1961, is vital for blood to clot normally. Despite it being given as standard medical practice since then, vitamin K-deficient bleeding (VKDB) is being seen more often in newborns than it has in decades. [More]
The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

Eli Lilly and Company announced that The Lancet Oncology has published results of the Phase III REACH trial that evaluated CYRAMZA (ramucirumab) as a second-line treatment for people with hepatocellular carcinoma (HCC), also known as liver cancer. While the REACH trial's primary endpoint of overall survival favored the CYRAMZA arm, it was not statistically significant. [More]
Breastfeeding Medicine editorial examines risks associated with Internet-purchased breast milk

Breastfeeding Medicine editorial examines risks associated with Internet-purchased breast milk

The practice of breast milk sharing among mothers has evolved into an Internet-based marketplace in which this valuable commodity is being bought and sold not only to feed babies, but as a "natural superfood" for body builders and athletes. [More]
Orange sweet potato reduces prevalence and duration of diarrhea in children

Orange sweet potato reduces prevalence and duration of diarrhea in children

A new study has found that orange sweet potato (OSP) reduced both the prevalence and duration of diarrhea in young children in Mozambique. [More]
Early support important to help mom breastfeed successfully

Early support important to help mom breastfeed successfully

Most women understand the benefits of breastfeeding their infants, but there are physical and emotional roadblocks that can make it a challenge for moms. During the first weeks of a baby's life it is vital for mom to be able to focus on caring for herself and nursing her infant. [More]
WHO's updated essential medicines list includes progesterone contraceptive vaginal ring

WHO's updated essential medicines list includes progesterone contraceptive vaginal ring

The World Health Organization released its 2015 updated essential medicines list and for the first time included the progesterone contraceptive vaginal ring (CVR), a contraceptive safe and effective for lactating women in the postpartum period. [More]
Protective antibody response could be effective in preventing mother-to-child HIV transmission

Protective antibody response could be effective in preventing mother-to-child HIV transmission

How most babies are protected from acquiring HIV from their infected mothers has been a matter of scientific controversy. [More]
Maternal obesity increases health risks for mothers and their babies

Maternal obesity increases health risks for mothers and their babies

Women with obesity have a range of increased health risks in pregnancy, both for them and their babies, compared with those in the healthy weight category, according to a new systematic review of research by academics at the School of Nursing and Midwifery, Trinity College Dublin, the University of Gothenberg, and City University London. [More]
ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

Novartis today announced new data from two Phase II studies of Zykadia (ceritinib), as well as one Phase II study of Tafinlar® (dabrafenib) in combination with Mekinist (trametinib) in certain patients with non-small cell lung cancer. [More]
Helsinn's Akynzeo for CINV prevention receives EC approval

Helsinn's Akynzeo for CINV prevention receives EC approval

Helsinn, the Swiss Group focused on building quality cancer care, announces today that on 27th May 2015, the European Commission (EC) approved Akynzeo® (netupitant-palonosetron) for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin-based cancer chemotherapy and moderately emetogenic cancer chemotherapy in the European Union. [More]
Advertisement
Advertisement